SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 126.72+1.0%3:25 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Wilkes who wrote (74)11/1/1997 3:10:00 PM
From: dougjn  Read Replies (1) of 296
 
Tom, what do you think of Biogen? They have rising sales in some real products, and some very promising R&D...and they aren't expensive for a drug on next year's earnings. They slightly disappointed on aggressive numbers last two quarters due to somewhat slower of their arthritis drug in Europe. VL says on target now.
I don't hold yet but am tempted. They held up real well this past week.

Regards, Doug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News